Norges Bank’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-71,527
| Closed | -$293K | – | 1822 |
|
|
2024
Q2 | $293K | Sell |
71,527
-71,429
| -50% | -$292K | ﹤0.01% | 1905 |
|
|
2024
Q1 | $2.25M | Sell |
142,956
-21,386
| -13% | -$337K | ﹤0.01% | 1726 |
|
|
2023
Q4 | $2.49M | Hold |
164,342
| – | – | ﹤0.01% | 1776 |
|
|
2023
Q3 | $3.3M | Sell |
164,342
-3,400
| -2% | -$68.2K | ﹤0.01% | 1760 |
|
|
2023
Q2 | $4.73M | Sell |
167,742
-169,900
| -50% | -$4.79M | ﹤0.01% | 1732 |
|
|
2023
Q1 | $5.81M | Buy |
337,642
+105,654
| +46% | +$1.82M | ﹤0.01% | 1714 |
|
|
2022
Q4 | $4.67M | Hold |
231,988
| – | – | ﹤0.01% | 1797 |
|
|
2022
Q3 | $5.02M | Sell |
231,988
-100,056
| -30% | -$2.17M | ﹤0.01% | 1765 |
|
|
2022
Q2 | $9.33M | Buy |
332,044
+237,294
| +250% | +$6.67M | ﹤0.01% | 1585 |
|
|
2022
Q1 | $4.37M | Buy |
94,750
+40,967
| +76% | +$1.89M | ﹤0.01% | 1895 |
|
|
2021
Q4 | $4.52M | Hold |
53,783
| – | – | ﹤0.01% | 1924 |
|
|
2021
Q3 | $3.58M | Buy |
53,783
+13,877
| +35% | +$925K | ﹤0.01% | 1971 |
|
|
2021
Q2 | $2.12M | Buy |
39,906
+10,980
| +38% | +$584K | ﹤0.01% | 2013 |
|
|
2021
Q1 | $1.26M | Buy |
28,926
+19,082
| +194% | +$828K | ﹤0.01% | 2031 |
|
|
2020
Q4 | $511K | Buy |
+9,844
| New | +$511K | ﹤0.01% | 2080 |
|